PERSPECTA

News from every angle

← Back to headlines

Collegium Pharmaceutical Details 2026 Revenue Outlook and AZSTARYS Deal

Collegium Pharmaceutical provided its 2026 revenue outlook and elaborated on a $650 million AZSTARYS deal during the Needham Conference.

16 Apr, 01:01 — 16 Apr, 01:01
PostShare

Sources

Showing 1 of 1 sources
YahooMostly Factual8d ago

Collegium Pharmaceutical Sets 2026 Revenue Outlook, Details $650M AZSTARYS Deal at Needham Conference

Read full article →

Related Stories

Oil Jumps Above $100 After US-Iran Talks Fail

just now

Namita Thapar's Shark Tank India Season 2 Investment Reaches Rs 15 Crore Revenue

9m ago

Greek Luxury Housing Market Sees Strong Demand Amid Geopolitical Uncertainty

12m ago

JPMorgan Promotes Two Tech Dealmakers to Managing Director

16m ago